Shigefumi Maesaki Selected Research

Shigefumi Maesaki Research Topics

Disease

10	COVID-19 08/2023 - 01/2020
9	Infections 12/2023 - 01/2014
6	Sepsis (Septicemia) 08/2020 - 08/2000
3	Pneumonia (Pneumonitis) 01/2023 - 10/2021
3	Cryptococcosis 01/2016 - 01/2002
2	Candidemia 04/2024 - 01/2012
2	Inflammation (Inflammations) 09/2022 - 10/2021
2	Disease Progression 05/2022 - 05/2021
2	Hypoalbuminemia 10/2021 - 01/2015
2	Chagas Disease (American Trypanosomiasis) 02/2021 - 01/2019
2	Bronchitis 02/2021 - 02/2020
2	Common Cold 02/2021 - 02/2020
2	Mycoses (Diseases, Fungus) 12/2008 - 01/2002
1	Latent Tuberculosis 01/2023
1	Breakthrough Infections 01/2023
1	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2023
1	Connective Tissue Diseases (Connective Tissue Disease) 01/2023
1	Pneumocystis Pneumonia (Pneumocystis carinii Pneumonia) 01/2023
1	Miliary Tuberculosis 01/2023
1	Lymphoma (Lymphomas) 01/2023
1	Gonorrhea 12/2022
1	Disseminated Intravascular Coagulation 09/2022
1	Parkinson Disease (Parkinson's Disease) 09/2022
1	Edema (Dropsy) 10/2021
1	Purpura 10/2021
1	Hyperglycemia 10/2021
1	Communicable Diseases (Infectious Diseases) 02/2021
1	Syphilis 12/2020
1	Cholestasis 11/2020
1	Human Influenza (Influenza) 01/2020
1	Community-Acquired Infections 01/2018
1	Meningoencephalitis 01/2015
1	Hypoproteinemia 01/2015
1	Chronic Kidney Failure (Chronic Renal Failure) 12/2014
1	Infarction (Infarctions) 01/2012
1	Endocarditis 01/2012
1	Invasive Fungal Infections 01/2009
1	Febrile Neutropenia 01/2009

Drug/Important Bio-Agent (IBA)

5	Antifungal AgentsIBA 03/2014 - 01/2002
4	AntigensIBA 08/2023 - 01/2002
4	AntibodiesIBA 01/2023 - 01/2019
4	Immunoglobulin G (IgG)IBA 01/2023 - 01/2020
3	Immunoglobulin M (IgM)IBA 01/2022 - 01/2020
3	Carbapenems (Carbapenem Antibiotics)IBA 08/2020 - 04/2014
2	Anti-Bacterial Agents (Antibiotics)IBA 12/2023 - 01/2022
2	Therapeutic UsesIBA 12/2020 - 08/2000
2	MacrolidesIBA 12/2020 - 02/2020
2	GlycolipidsIBA 03/2014 - 01/2014
2	Interferon-gamma (Interferon, gamma)IBA 03/2014 - 08/2000
1	Vincristine (Oncovin)FDA LinkGeneric 01/2023
1	Rituximab (Mabthera)FDA Link 01/2023
1	mRNA VaccinesIBA 01/2023
1	BNT162 VaccineIBA 01/2023
1	polyglucosanIBA 01/2023
1	Procarbazine (Matulane)FDA Link 01/2023
1	Methotrexate (Mexate)FDA LinkGeneric 01/2023
1	QuinolonesIBA 12/2022
1	Nucleic AcidsIBA 12/2022
1	Peptides (Polypeptides)IBA 09/2022
1	Interleukin-8 (Interleukin 8)IBA 09/2022
1	Purinergic P1 Receptors (Adenosine Receptor)IBA 09/2022
1	Dopamine (Intropin)FDA LinkGeneric 09/2022
1	Interleukin-17 (Interleukin 17)IBA 09/2022
1	Proteins (Proteins, Gene)FDA Link 09/2022
1	Dacarbazine (DIC)FDA LinkGeneric 09/2022
1	InterleukinsIBA 09/2022
1	Oxygen (Dioxygen)IBA 05/2022
1	EnzymesIBA 12/2021
1	Blood Glucose (Blood Sugar)IBA 10/2021
1	fibrin fragment D (D-dimer)IBA 10/2021
1	Angiotensin-Converting Enzyme 2IBA 10/2021
1	Insulin (Novolin)FDA Link 10/2021
1	Recombinant ProteinsIBA 02/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	BilirubinIBA 11/2020
1	Guanosine Triphosphate (GTP)IBA 11/2020
1	Anti-Infective Agents (Microbicides)IBA 08/2020
1	Imipenem FDA Link 08/2020
1	RNA (Ribonucleic Acid)IBA 01/2020
1	DNA (Deoxyribonucleic Acid)IBA 11/2019
1	16S Ribosomal RNAIBA 08/2019
1	carbapenemaseIBA 11/2018
1	Ampicillin (Omnipen)FDA LinkGeneric 01/2018
1	Penicillins (Penicillin)FDA Link 01/2018
1	AzolesIBA 01/2015
1	SteroidsIBA 01/2015
1	C-Reactive ProteinIBA 01/2015
1	Cefotaxime (Kendrick)FDA LinkGeneric 12/2014
1	Vancomycin FDA LinkGeneric 01/2012
1	EchinocandinsIBA 01/2009

Therapy/Procedure

4	Therapeutics 04/2024 - 12/2008
2	Drug Therapy (Chemotherapy) 01/2023 - 02/2021
2	Aftercare (After-Treatment) 01/2023 - 01/2015
2	Central Venous Catheters 12/2014 - 04/2004
1	Mechanical Ventilators (Ventilator) 11/2020
1	Length of Stay 11/2018
1	Lasers (Laser) 01/2016
1	Withholding Treatment 01/2015
1	Duration of Therapy 01/2015
1	Urinary Catheters 12/2014